Targeting the vitamin biosynthesis pathways for the treatment of malaria

Future Medicinal Chemistry

Volumn 5, Issue 7, 2013, Pages 769-779

  Kronenberger, Thales ^a   Schettert, Isolmar ^a   Wrenger, Carsten ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); ANTIMALARIAL AGENT; COCARBOXYLASE; FOLIC ACID ANTAGONIST; GLYCERALDEHYDE 3 PHOSPHATE; OXOGLUTARATE DEHYDROGENASE; PYRIDOXAL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE; PYRIDOXINE; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; PYRUVATE DEHYDROGENASE; RIBOSE 5 PHOSPHATE; SULFANILAMIDE DERIVATIVE; THIAMINE; THIAMINE PHOSPHATE; THIAMINE TRIPHOSPHATE; TRANSCRIPTION FACTOR PDX 1;

AMINO ACID METABOLISM; CATALYSIS; DEFENSE MECHANISM; DEPHOSPHORYLATION; DNA REPLICATION; DRUG EFFICACY; DRUG METABOLISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SPECIFICITY; FOLATE METABOLISM; HUMAN; MALARIA; NONHUMAN; OXIDATIVE STRESS; PLASMODIUM FALCIPARUM; POLYAMINE METABOLISM; PRIORITY JOURNAL; PURINE SYNTHESIS; REVIEW; TRANSAMINATION; VITAMIN BIOSYNTHESIS; VITAMIN METABOLISM;

ANTIMALARIALS; ENZYME INHIBITORS; HUMANS; MALARIA; PLASMODIUM; PROTOZOAN PROTEINS; THIAMINE; VITAMIN B 6;

EID: 84877623608     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.43     Document Type: Review

References (67)

1. Burrows JN. Antimalarial drug discovery: where next? Future Med. Chem. 4(18), 2233-2235
2. World Health Organisation. World Malaria Report 2011. WHO Press, Geneva, Switzerland (2012).
3. Sabbatani S, Fiorino S, Manfredi R. The emerging of the fifth malaria parasite (Plasmodium knowlesi): a public health concern? Braz. J. Infect. Dis. 14(3), 299-309 (2010).
4. Greenwood BM, Fidock DA, Kyle DE, et al. Malaria: progress, perils, and prospects for eradication. J. Clin. Invest. 118(4), 1266-1276 (2008).
5. Mahajan SS, Gut J, Rosenthal PJ, Renslo AR. Ferrous iron-dependent delivery of therapeutic agents to the malaria parasite. Future Med. Chem. 4(18), 2241-2249 (2012).
6. Bhattarai A, Ali AS, Kachur SP, et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 4(11), e309 (2007).
7. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361(5), 455-467 (2009).
8. Müller IB, Hyde JE. Antimalarial drugs: modes of action and mechanisms of parasite resistance. Future Microbiol. 5(12), 1857-1873 (2010).
9. Nzila A, Ward SA, Marsh K, Sims PF, Hyde JE. Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy. Trends Parasitol. 21(6), 292-298 (2005).
10. Hyde JE. Drug-resistant malaria. Trends Parasitol. 21(11), 494-498 (2005).
11. Hyde JE. Drug-resistant malaria - an insight. FEBS J. 274(18), 4688-4698 (2007).
12. Müller IB, Hyde JE, Wrenger C. Vitamin B metabolism in Plasmodium falciparum as a source of drug targets. Trends Parasitol. 26(1), 35-43 (2010).
13. Schellenberg KA, Coatney GR. The influence of antimalarial drugs on nucleic acid synthesis in Plasmodium gallinaceum and Plasmodium berghei. Biochem. Pharmacol. 6, 143-152 (1961).
14. Salcedo-Sora JE, Ochong E, Beveridge S, et al. The molecular basis of folate salvage in Plasmodium falciparum: characterization of two folate transporters. J. Biol. Chem. 286(52), 44659-44668 (2011).
15. Nair S, Miller B, Barends M, et al. Adaptive copy number evolution in malaria parasites. PLoS Genet. 4(10), e1000243 (2008).
16. Dittrich S, Mitchell SL, Blagborough AM, et al. An atypical orthologue of 6-pyruvoyltetrahydropterin synthase can provide the missing link in the folate biosynthesis pathway of malaria parasites. Mol. Microbiol. 67(3), 609-618 (2008).
17. Olliaro P. Mode of action and mechanisms of resistance for antimalarial drugs. Pharmacol. Ther. 89(2), 207-219 (2001).
18. Nduati E, Diriye A, Ommeh S, et al. Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer. Parasitol. Res. 102(6), 1227-1234 (2008).
19. Bunnag D, Harinasuta T. Studies on the chemotherapy of human opisthorchiasis in Thailand: I. Clinical trial of praziquantel. Southeast Asian J. Trop. Med. Public Health 11(4), 528-531 (1980).
20. Mahan LC, Escott-Stump S, Raymond JL, Krause MV. Krause's Food & the Nutrition Care Process. Saunders Elsevier, MO, USA (2012).
21. Makarchikov AF, Lakaye B, Gulyai IE, et al. Thiamine triphosphate and thiamine triphosphatase activities: from bacteria to mammals. Cell Mol. Life Sci. 60(7), 1477-1488 (2003).
22. Pohl M, Sprenger GA, Muller M. A new perspective on thiamine catalysis. Curr Opin. Biotechnol. 15(4), 335-342 (2004).
23. Haas RH. Thiamine and the brain. Annu. Rev. Nutr. 8, 483-515 (1988).
24. Friedrich W. Vitamins. Walter de Gruyter, Berlin, Germany (1988).
25. Begley TP, Downs DM, Ealick SE, et al. Thiamin biosynthesis in prokaryotes. Arch Microbiol. 171(5), 293-300 (1999).
26. Wightman R, Meacock PA. The THI5 gene family of Saccharomyces cerevisiae: distribution of homologues among the hemiascomycetes and functional redundancy in the aerobic biosynthesis of thiamin from pyridoxine. Microbiology 149(Pt 6), 1447-1460 (2003).
27. Wrenger C, Eschbach ML, Müller IB, Laun NP, Begley TP, Walter RD. Vitamin B1 de novo synthesis in the human malaria parasite Plasmodium falciparum depends on external provision of 4-amino-5- hydroxymethyl-2-methylpyrimidine. Biol. Chem. 387(1), 41-51 (2006).
28. Divo AA, Geary TG, Davis NL, Jensen JB. Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth. J. Protozool. 32(1), 59-64 (1985).
29. Reddick JJ, Kinsland C, Nicewonger R, et al. Overexpression, purification and characterization of two pyrimidine kinases involved in the biosynthesis of thiamin: 4-amino-5-hydroxymethyl-2- methylpyrimidine kinase and 4-amino-5- hydroxymethyl-2-methylpyrimidine phosphate kinase. Tetrahedron 54(52), 159873-115991 (1998).
30. Müller S, Kappes B. Vitamin and cofactor biosynthesis pathways in Plasmodium and other apicomplexan parasites. Trends Parasitol. 23(3), 112-121 (2007).
31. Zhang Y, Taylor SV, Chiu HJ, Begley TP. Characterization of the Bacillus subtilis ThiC operon involved in thiamine biosynthesis. J. Bacteriol. 179(9), 3030-3035 (1997).
32. Hohmann S, Meacock PA. Thiamin metabolism and thiamin diphosphate-dependent enzymes in the yeast Saccharomyces cerevisiae: genetic regulation. Biochim. Biophys. Acta 1385(2), 201-219 (1998).
33. Morett E, Korbel JO, Rajan E, et al. Systematic discovery of analogous enzymes in thiamin biosynthesis. Nat. Biotechnol. 21(7), 790-795 (2003).
34. Peapus DH, Chiu HJ, Campobasso N, Reddick JJ, Begley TP, Ealick SE. Structural characterization of the enzyme-substrate, enzyme-intermediate, and enzyme-product complexes of thiamin phosphate synthase. Biochemistry 40(34), 10103-10114 (2001).
35. Eschbach ML, Müller IB, Gilberger TW, Walter RD, Wrenger C. The human malaria parasite Plasmodium falciparum expresses an atypical N-terminally extended pyrophosphokinase with specificity for thiamine. Biol. Chem. 387(12), 1583-1591 (2006).
36. Knöckel J, Bergmann B, Müller IB, Rathaur S, Walter RD, Wrenger C. Filling the gap of intracellular dephosphorylation in the Plasmodium falciparum vitamin B1 biosynthesis. Mol. Biochem. Parasitol. 157(2), 241-243 (2008).
37. Lawhorn BG, Gerdes SY, Begley TP. A genetic screen for the identification of thiamin metabolic genes. J. Biol. Chem. 279(42), 43555-43559 (2004).
38. Percudani R, Peracchi A. A genomic overview of pyridoxal-phosphate- dependent enzymes. EMBO Rep. 4(9), 850-854 (2003).
39. Wu F, Christen P, Gehring H. A novel approach to inhibit intracellular vitamin B6-dependent enzymes: proof of principle with human and plasmodium ornithine decarboxylase and human histidine decarboxylase. FASEB J. 25(7), 2109-2122 (2011).
40. Wu F, Gehring H. Structural requirements for novel coenzyme-substrate derivatives to inhibit intracellular ornithine decarboxylase and cell proliferation. FASEB J. 23(2), 565-574 (2009).
41. Fitzpatrick TB, Amrhein N, Kappes B, Macheroux P, Tews I, Raschle T. Two independent routes of de novo vitamin B6 biosynthesis: not that different after all. Biochem. J. 407(1), 1-13 (2007).
42. Roa BB, Connolly DM, Winkler ME. Overlap between pdxA and ksgA in the complex pdxA-ksgA-apaG-apaH operon of Escherichia coli K-12. J. Bacteriol. 171(9), 4767-4777 (1989).
43. Lam HM, Tancula E, Dempsey WB, Winkler ME. Suppression of insertions in the complex pdxJ operon of Escherichia coli K-12 by lon and other mutations. J. Bacteriol. 174(5), 1554-1567 (1992).
44. Müller IB, Das Gupta R, Lüersen K, Wrenger C, Walter RD. Assessing the polyamine metabolism of Plasmodium falciparum as chemotherapeutic target. Mol. Biochem. Parasitol. 160(1), 1-7 (2008).
45. Knöckel J, Müller IB, Bergmann B, Walter RD, Wrenger C. The apicomplexan parasite Toxoplasma gondii generates pyridoxal phosphate de novo. Mol. Biochem. Parasitol. 152(1), 108-111 (2007).
46. Padilla PA, Fuge EK, Crawford ME, Errett A, Werner-Washburne M. The highly conserved, coregulated SNO and SNZ gene families in Saccharomyces cerevisiae respond to nutrient limitation. J. Bacteriol. 180(21), 5718-5726 (1998).
47. Osmani AH, May GS, Osmani SA. The extremely conserved pyroA gene of Aspergillus nidulans is required for pyridoxine synthesis and is required indirectly for resistance to photosensitizers. J. Biol. Chem. 274(33), 23565-23569 (1999).
48. Ehrenshaft M, Jenns AE, Chung KR, Daub ME. SOR1, a gene required for photosensitizer and singlet oxygen resistance in Cercospora fungi, is highly conserved in divergent organisms. Mol. Cell 1(4), 603-609 (1998).
49. Ehrenshaft M, Bilski P, Li MY, Chignell CF, Daub ME. A highly conserved sequence is a novel gene involved in de novo vitamin B6 biosynthesis. Proc. Natl Acad. Sci. USA 96(16), 9374-9378 (1999).
50. Belitsky BR. Physical and enzymological interaction of Bacillus subtilis proteins required for de novo pyridoxal 5́-phosphate biosynthesis. J. Bacteriol. 186(4), 1191-1196 (2004).
51. Raschle T, Amrhein N, Fitzpatrick TB. On the two components of pyridoxal 5́-phosphate synthase from Bacillus subtilis. J. Biol. Chem. 280(37), 32291-32300 (2005).
52. Burns KE, Xiang Y, Kinsland CL, Mclafferty FW, Begley TP. Reconstitution and biochemical characterization of a new pyridoxal-5́-phosphate biosynthetic pathway. J. Am. Chem. Soc. 127(11), 3682-3683 (2005).
53. Strohmeier M, Raschle T, Mazurkiewicz J, et al. Structure of a bacterial pyridoxal 5́-phosphate synthase complex. Proc. Natl Acad. Sci. USA 103(51), 19284-19289 (2006).
54. Bauer JA, Bennett EM, Begley TP, Ealick SE. Three-dimensional structure of YaaE from Bacillus subtilis, a glutaminase implicated in pyridoxal-5́- phosphate biosynthesis. J. Biol. Chem. 279(4), 2704-2711 (2004).
55. Zhu J, Burgner JW, Harms E, Belitsky BR, Smith JL. A new arrangement of (beta/alpha)8 barrels in the synthase subunit of PLP synthase. J. Biol. Chem. 280(30), 27914-27923 (2005).
56. Zein F, Zhang Y, Kang YN, Burns K, Begley TP, Ealick SE. Structural insights into the mechanism of the PLP synthase holoenzyme from Thermotoga maritima. Biochemistry 45(49), 14609-14620 (2006).
57. Cassera MB, Gozzo Fc, D'alexandri Fl, et al. The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum. J. Biol. Chem. 279(50), 51749-51759 (2004).
58. Wrenger C, Eschbach ML, Müller IB, Warnecke D, Walter RD. Analysis of the vitamin B6 biosynthesis pathway in the human malaria parasite Plasmodium falciparum. J. Biol. Chem. 280(7), 5242-5248 (2005).
59. Gengenbacher M, Fitzpatrick TB, Raschle T, et al. Vitamin B6 biosynthesis by the malaria parasite Plasmodium falciparum: biochemical and structural insights. J. Biol. Chem. 281(6), 3633-3641 (2006).
60. Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, Ginsburg H. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int. J. Parasitol. 34(2), 163-189 (2004).
61. Müller S. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol. Microbiol. 53(5), 1291-1305 (2004).
62. Müller S, Gilberger TW, Krnajski Z, Luersen K, Meierjohann S, Walter RD. Thioredoxin and glutathione system of malaria parasite Plasmodium falciparum. Protoplasma 217(1-3), 43-49 (2001).
63. Rahlfs S, Schirmer RH, Becker K. The thioredoxin system of Plasmodium falciparum and other parasites. Cell Mol. Life Sci. 59(6), 1024-1041 (2002).
64. Knöckel J, Müller IB, Butzloff S, Bergmann B, Walter RD, Wrenger C. The antioxidative effect of de novo generated vitamin B6 in Plasmodium falciparum validated by protein interference. Biochem. J. 443(2), 397-405 (2012).
65. Reeksting SB, Müller IB, Burger PB, et al. Exploring inhibition of Pdx1, a component of the PLP synthase complex of the human malaria parasite Plasmodium falciparum. Biochem. J. 449(1), 175-187 (2013).
66. Müller IB, Wu F, Bergmann B, et al. Poisoning pyridoxal 5-phosphate-dependent enzymes: a new strategy to target the malaria parasite Plasmodium falciparum. PLoS ONE 4(2), e4406 (2009).
67. Smithson DC, Lee J, Shelat AA, Phillips MA, Guy RK. Discovery of potent and selective inhibitors of Trypanosoma brucei ornithine decarboxylase. J. Biol. Chem. 285(22), 16771-16781 (2008).